Arafath K Najumudeen

13PUBLICATIONS
161CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

|Nov 13, 2024
Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβ.

Christos Kiourtis, Maria Terradas-Terradas, Lucy M Gee

|Sep 12, 2024
SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers.

Johanna Lilja, Jasmin Kaivola, James R W Conway

|Jan 03, 2024
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo.

Arafath K Najumudeen, Sigrid K Fey, Laura M Millett

|Aug 14, 2023
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target.

Johan Vande Voorde, Rory T Steven, Arafath K Najumudeen

Pageof 3